Asociatia Obgteasci "Lnifiativa Pozitivi" (Ngo, Hiv Cbo) Opposition, Bedaquiline, (Ea 009779 B1 /Wo2006067048 A1, Ea 010651 B1 /Wo2005117875 A1, Ea 017091 B9 /Wo2008068231 A1)
No Annotations
Alert me when there are new annotations for this document
10 similar patent oppositions
-
Ganesh Acharya and Delhi Network of Positive People (DNP+) opposition, Bedaquiline Long Acting Formulation, (IN202017005443)
Countries: India Date: 2021
-
People Plus Non-Governmental Organization opposition, Bedaquiline, (EA017091 (B1) / WO2008068231A1)
Countries: Belarus Date: 2021
-
Delhi Network of Positive People opposition, GSK3036656, (201717032083)
Countries: India Date: 2021
-
Delhi Network of Positive People opposition, Lenacapavir, (201917006277)
Countries: India Date: 2021
-
Sankalp Rehabilitation Trust opposition, Lenacapavir, (202017010006)
Countries: India Date: 2021
-
Sankalp Rehabilitation Trust opposition, Lenacapavir, (202017007904)
Countries: India Date: 2021
-
Sankalp Rehabilitation Trust opposition, Lenacapavir, (7440/DELNP/2015)
Countries: India Date: 2021
-
Sankalp Rehabilitation Trust opposition, Lenacapavir, (202018020805)
Countries: India Date: 2021
-
AIDS ACCESS FOUNDATION AND THAI NETWORK FOR PEOPLE WITH HIV/AIDS opposition, Doravirine, (WO/2011/120133)
Countries: Thailand Date: 2021
-
Fundación Grupo Efecto Positivo opposition, Doravirine (NNRTI), (ARP110101028)
Countries: Argentina Date: 2021